The World Health Organization (WHO) has designated a new strain of Covid-19 -- 'EG.5' or 'Eris' as a "variant of interest" as cases rise globally.
"EG.5 is a descendent lineage of XBB.1.9.2, which has the same spike amino acid profile as XBB.1.5. EG.5 was first reported on February 17, 2023, and designated as a variant under monitoring (VUM) on July 19, 2023. With this risk evaluation, we are designating EG.5 and its sub-lineages as a variant of interest (VOI)," WHO said on Wednesday.
As of August 7, around 7,354 sequences of EG.5 have been submitted to GISAID (Global Initiative on Sharing All Influenza Data) from 51 countries.
According to WHO, the largest portion of EG.5 sequences are from China (30.6 per cent, 2247 sequences).
The other countries with at least 100 sequences are the US (18.4 per cent, 1356 sequences), the Republic of Korea (14.1 per cent, 1040 sequences), Japan (11.1 per cent, 814 sequences), Canada (5.3 per cent, 392 sequences), Australia (2.1 per cent, 158 sequences), Singapore (2.1 per cent, 154 sequences), the UK (2.0 per cent, 150 sequences), France (1.6 per cent, 119 sequences), Portugal (1.6 per cent, 115 sequences), and Spain (1.5 per cent, 107 sequences).
However, the WHO believes the variant does not pose a significant risk.
"Based on the available evidence, the public health risk posed by EG.5 is evaluated as low at the global level," WHO stated, adding that the risk appeared to be comparable to that of other circulating variants of interest.
"While EG.5 has shown increased prevalence, growth advantage, and immune escape properties, there have been no reported changes in disease severity to date," it added.
As with Omicron, the most common symptoms of EG.5.1 include runny nose, headache, fatigue (mild or severe), sneezing and sore throat, as per the Zoe Study app.
India leads global AI adoption with 30pc companies maximising AI value: Report
India leads Artificial Intelligence (AI) adoption with 30 per cent of companies in the country having maximised AI’s value potential -- surpassing the global average of 26 per cent, according to a report.
IIT Madras, ISRO to study spacecraft & launch vehicle-related thermal management
The Indian Institute of Technology (IIT) Madras on Monday announced a collaboration with the Indian Space Research Organisation (ISRO) to establish a Centre of Excellence (CoE) for research in ‘Fluid and Thermal Sciences’.
Scientists to probe if grape juice chemical can prevent bowel cancer
The team will probe a chemical called resveratrol -- a naturally occurring ingredient found in grapes, blueberries, raspberries, and peanuts -- for potential cancer prevention.
Musk’s SpaceX wins $733 million launch contract from US Space Force
The US Space Force’s Space Systems Command issued Launch Service Task Orders (LSTOs) totalling $733,566,001 to SpaceX under the “National Security Space Launch Phase 3 Lane 1.”
India takes lead in 6G after record 5G roll out: Experts
After a successful 5G rollout, the country is now taking lead in 6G as the ‘Digital India’ initiative transforms the economy, with the Jan Dhan, Aadhaar and Mobile (JAM) trinity emerging as a solid foundation block, experts said here on Friday.
NASA-SpaceX's Europa Clipper off to explore Jupiter's ocean world
"Today, we embark on a new journey across the solar system in search of the ingredients for life within Jupiter's icy moon. Our next chapter in space exploration has begun," he added.
Indian conglomerates set to spend $800 bn on growth, new businesses in focus
Indian conglomerates are likely to spend about $800 billion on growth over the next 10 years, almost triple of what they spent over the prior decade, a report showed on Monday.
NASA’s Europa Clipper mission to lift off on Monday: SpaceX
After being stalled due to hurricane Milton, NASA’s Europa Clipper mission aims to fly to Jupiter’s icy moon Europa in search of life on Monday, SpaceX has said.